Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06501872 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Physician-Modified Fenestrated and Branched Aortic Endografting for the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
A NA study of Aortic Aneurysm, sponsored by Bjoern D. Suckow.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06501872: Recruiting NA study of Aortic Aneurysm, sponsored by Bjoern D. Suckow.
NCT06501872 is a NA study of Aortic Aneurysm that is actively recruiting participants, run by Bjoern D. Suckow. The registered enrollment target is 80 participants, below the 634-participant average among 14 other Aortic Aneurysm trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06501872, a NA study of Aortic Aneurysm, is actively recruiting participants, sponsored by Bjoern D. Suckow.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary clinical objective of this study is to evaluate the safety and effectiveness of a physician-modified, fenestrated and branched aortic endoprosthesis for the treatment of thoracoabdominal aortic aneurysms (TAAAs). The goal of the primary analysis is to demonstrate both the safety and effectiveness of using a physician-modified fenestrated Cook Zenith Alpha Thoracic Endovascular Graft as compared to previously published results of open surgical replacement of the aneurysmal aorta.
Primary Outcome
Percent of patients who survive 30 days following surgery
Conditions Studied
Interventions
- DEVICE Physician-modified aortic endograft
Study Locations (1)
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-12-10 |
| Est. Completion | 2031-09 |
| Phase | NA |
What NCT06501872 shows while recruiting
NCT06501872 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 634-participant average among 14 other Aortic Aneurysm trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Physician-modified aortic endograft is the first listed.
NCT06501872 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT06501872 about?
NCT06501872 is a clinical study titled "Safety and Effectiveness of Physician-Modified Fenestrated and Branched Aortic Endografting for the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms". The primary clinical objective of this study is to evaluate the safety and effectiveness of a physician-modified, fenestrated and branched aortic endoprosthesis for the treatment of thoracoabdominal aortic aneurysms (TAAAs). The goal of the primary analysis is to demonstrate both the safety and effe...
What is the current status of trial NCT06501872?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-12-10. Estimated completion is 2031-09.
What conditions does trial NCT06501872 study?
This clinical trial studies the following conditions: Aortic Aneurysm.
What interventions are being tested in trial NCT06501872?
The interventions under investigation include: Physician-modified aortic endograft (DEVICE).
Who is sponsoring clinical trial NCT06501872?
This trial is sponsored by Bjoern D. Suckow, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06501872 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06501872's enrollment target sits among peer trials
80 9th of 14 higher than 6 of 14 other Aortic Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Physiology in Patients With Aortic Aneurysm and Its Correlation With Mechanical Properties of Aortic Tissue
RECRUITING · NA
-
Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms
RECRUITING · NA
-
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
RECRUITING · NA
-
Prehabilitation for Aortic Aneurysm Surgery: Proof-of-concept Trial
RECRUITING · NA
-
Laser In Situ Fenestration Study
RECRUITING · NA
-
Radiation Free Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI